1.
Br J Dermatol
; 181(1): 202-203, 2019 07.
Article
in English
| MEDLINE
| ID: mdl-30609008
Subject(s)
Antibodies, Monoclonal, Humanized/adverse effects , Dermatologic Agents/adverse effects , Latent Tuberculosis/epidemiology , Psoriasis/drug therapy , Adult , Clinical Trials as Topic , Female , Humans , Interleukin-17/antagonists & inhibitors , Interleukin-17/immunology , Latent Tuberculosis/diagnosis , Latent Tuberculosis/immunology , Male , Middle Aged , Prevalence , Psoriasis/diagnosis , Psoriasis/immunology , Severity of Illness Index , Treatment Outcome , Tuberculin Test
2.
Pa Med
; 81(10): 21-2, 1978 Oct.
Article
in English
| MEDLINE
| ID: mdl-704105